Publication

Antibiotic resistance threats in the United States, 2013 (Report)

Authored by:

Centers for Disease Control and Prevention

Full Citation:

Centers for Disease Control and Prevention 2013. Antibiotic resistance threats in the United States, 2013 (Report).

Additional key concepts from this publication:

The use of vaccines is a critical step in controlling the occurrence of antibiotic-resistant infections.

Key Evidence: The US CDC identifies the use of vaccines as one of the 4 critical steps for controlling the spread of antibiotic resistance.

Antimicrobial-resistant infections are expensive to treat and place an economic burden on families and health systems.

Key Evidence: The US CDC estimates that antibiotic resistant pneumococcal infections in the US add $96 million to the costs of treatment each year.

World travel can perpetuate the spread of multi-drug resistant strains of disease that could be prevented through immunization.

Key Evidence: TB and pneumococcal infections are two of 18 drug-resistant threats to US health security identified by the CDC in 2013 and are potentially vaccine-preventable. Most antibiotic resistant TB infections in the US occur in people born outside the US.